Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
NCC Group | NZB | 22. nov 2024 | 1.84 | 0.00 |
NCI | NCL | 22. nov 2024 | 2.64 | -8.33 |
Ncino | 6NCA | 22. nov 2024 | 38.60 | +1.58 |
NCR Corporation | NCR1 | 22. nov 2024 | 13.90 | +3.73 |
NCS Multistage Holdings, Inc. | MUH0 | 22. nov 2024 | 22.00 | 0.00 |
ND PAPER | N3Y | 22. nov 2024 | 0.40 | +7.45 |
NE ELECTRIC | NE4H | 22. nov 2024 | 0.02 | -4.00 |
NEC Corporation | NEC1 | 22. nov 2024 | 74.82 | +1.08 |
Nedap (Nederlandsche Apparatenf) NV | NE3 | 22. nov 2024 | 51.80 | -0.38 |
Nedbank Group Ltd. | NCO | 22. nov 2024 | 15.50 | +0.65 |
NEDERMAN HLDG AB | 5QR | 22. nov 2024 | 19.00 | +1.06 |
Neinor Homes | 1NN | 22. nov 2024 | 15.20 | +0.53 |
Nekkar | 0TT | 22. nov 2024 | 0.72 | -0.28 |
Nektar Therapeutics | ITH | 22. nov 2024 | 0.95 | -0.21 |
NEL | D7G | 22. nov 2024 | 0.25 | +0.43 |
Nel ASA Unsponsored ADR (Norway) | D7GA | 22. nov 2024 | 7.20 | +2.13 |
Nelly Group | CD20 | 22. nov 2024 | 2.37 | +4.64 |
Nelnet, Inc. | NIJ | 22. nov 2024 | 100.00 | +0.50 |
NEMETSCHEK UNSP.ADR/0,2 | NEM0 | 22. nov 2024 | 18.80 | -0.53 |
Nemetschek SE | NEM | 22. nov 2024 | 99.80 | +0.30 |
NENT Group B | NEB | 22. nov 2024 | 0.06 | -0.71 |
Neo Performance Materials Inc | N14 | 22. nov 2024 | 5.08 | 0.00 |
NEO-NEON | N2L | 22. nov 2024 | 0.04 | +0.80 |
Neodecortech S.p.a. | FM2 | 22. nov 2024 | 2.70 | 0.00 |
Neoen S.A. | N1N | 22. nov 2024 | 39.26 | +0.05 |
NEOENERGIA UNSP.ADR 1 | 2Q40 | 22. nov 2024 | 12.70 | +9.48 |
Neogen Corporation | NG2 | 22. nov 2024 | 13.70 | -1.44 |
NeoGenomics, Inc. | NG9 | 22. nov 2024 | 15.70 | +9.03 |
Neolife | 8JB | 22. nov 2024 | 0.05 | -0.60 |
Neometals Ltd | 9R9 | 22. nov 2024 | 0.05 | -1.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.